The direct-medical costs associated with interferon-based treatment for hepatitis C in Vietnam
<p><strong>Background:</strong><br> Injectable interferon-based therapies have been used to treat hepatitis C virus (HCV) infection since 1991. International guidelines have now moved away from interferon-based therapy towards direct-acting antiviral (DAA) tablet regimens, be...
| Egile Nagusiak: | , , , , , , , , , , , , , |
|---|---|
| Formatua: | Journal article |
| Hizkuntza: | English |
| Argitaratua: |
F1000Research
2020
|